Ad is loading...
MENU
CRVS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Corvus Pharmaceuticals (CRVS) Earnings Date & Reports

A.I. Advisor
published Earnings

CRVS is expected to report earnings to fall 80.42% to -11 cents per share on March 06

Corvus Pharmaceuticals CRVS Stock Earnings Reports
Q4'24
Est.
$-0.12
Q3'24
Missed
by $0.49
Q2'24
Beat
by $0.05
Q1'24
Est.
$-0.12
Q4'23
Missed
by $0.02
The last earnings report on November 12 showed earnings per share of -60 cents, missing the estimate of -10 cents. With 2.35M shares outstanding, the current market capitalization sits at 526.27M.
View a ticker or compare two or three
CRVS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of anticancer immuno-oncology drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
863 Mitten Road
Phone
+1 650 900-4520
Employees
28
Web
https://www.corvuspharma.com